Skip to main content
Equibles
HCSG logo

HCSG · Healthcare Services Group Inc · Metrics

Track HCSG — free

Use HCSG with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research HCSG.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$20.53 +0.08 (+0.39%)
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$1.44B
Shares
68.63M
Volume · Oct 1 33.57K Avg daily vol (3M) 704.27K

HCSG metrics

76 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$20.45
Market cap
$1.44B

Price action

20 metrics
Price change (1W)
-3.1%
Price change (30D)
-5.0%
Price change (3M)
-14.9%
Price change (6M)
+12.7%
Price change (YTD)
+9.3%
Price change (1Y)
+26.7%
Trailing year
Price change (5Y)
-18.0%
52-week high
$25.31
52-week low
$15.18
Change from 52-week high
-17.4%
Change from 52-week low
+37.7%
Annualized volatility
42.0%
Annualized volatility (3M)
27.4%
Beta
0.8
RSI (14D)
35.3
Price vs SMA 50
-5.8%
Price vs SMA 200
-0.8%
Avg volume (3M)
703,218
Relative volume
0.7
Average dollar volume
$15.94M

Company

3 metrics
Sector
Healthcare
Industry
Medical Care Facilities
Shares outstanding
68.63M

Valuation

12 metrics
P / E (TTM)
12.2
Trailing earnings · reciprocal yield 8.2%
PEG ratio
0.2
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
0.8×
reciprocal yield 129.1%
P / book
2.8
reciprocal yield 35.9%
FCF yield
10.3%
TTM · current market cap
Buyback yield
6.4%
P / FCF
9.7
reciprocal yield 10.3%
P / operating cash flow
9.4
reciprocal yield 10.7%
Earnings yield
8.5%

Historical valuation

8 metrics
P / E historical average (3Y)
21.0×
reciprocal yield 4.8%
P / E historical average (5Y)
27.3×
reciprocal yield 3.7%
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
2026-10-21
Last earnings
2026-07-22

Profitability

9 metrics
Gross margin
17.1%
Operating margin
—
Trailing 12 months
Net margin
6.6%
Gross profit (TTM)
—
Operating profit (TTM)
—
Net income (TTM)
$122.95M
Trailing 12 months
Diluted EPS (TTM)
$1.71
FCF margin
8.0%
Effective tax rate
18.8%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$7.33

Growth

11 metrics
Revenue growth YoY
+2.7%
Year over year
Net income growth YoY
+49.6%
Revenue (TTM)
$1.86B
Trailing 12 months
EPS growth YoY
+52.8%
Shares change YoY
-4.5%
Year over year · fewer shares
Revenue CAGR (3Y)
+2.8%
Revenue CAGR (5Y)
+0.9%
EPS CAGR (3Y)
+20.8%
EPS CAGR (5Y)
-9.3%
FCF CAGR (3Y)
—
FCF CAGR (5Y)
-8.2%

Quality

14 metrics
Return on equity
23.7%
Return on assets
15.0%
Debt / equity
—
Current ratio
3.0
EBITDA (TTM)
—
Free cash flow (TTM)
$148.54M
Quick ratio
2.9
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$164.72M
Latest balance sheet
Cash & equivalents
$123.41M
Total assets
$820.86M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$154.28M
Capital expenditures (TTM)
$5.74M
R&D (TTM)
—
SG&A (TTM)
$191.32M
Stock compensation (TTM)
$11.31M
R&D / revenue
—
Stock compensation / revenue
0.6%

Ownership (13F)

3 metrics
13F filers
274
13F filer change QoQ
+14
Institutional ownership
104.2%

Short interest

3 metrics
Short interest
4.4%
Latest settlement · 5.8 days to cover
Days to cover
5.8d
Short-squeeze score
58 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$362,498
Insider-sentiment score
42 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 731012 CUSIP 421906108 13F (30d) 8 filings 8 filers Visit website Investor relations